Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Immunovant, Inc. (IMVT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-22Mar-31-21Mar-31-20Mar-31-19
   10-K10-K10-K10-K
Revenues  0.00.00.00.0
Cost of goods sold  0.00.00.00.0
Gross profit  0.00.00.00.0
Selling, general and administrative   [+]54.239.518.22.7
Research and development  101.868.647.925.7
EBITDA   [+]-155.9-108.1-66.1-28.4
Depreciation and amortization  0.10.10.00.0
EBIT   [+]-156.0-108.1-66.1-28.4
Interest expense    0.6 
Other income (expense), net  -0.80.30.4-0.2
Pre-tax income  -156.8-107.8-66.3-28.6
Income taxes  -0.1-0.40.10.0
            Tax rate  0.1%0.3%  
Net income  -156.7-107.4-66.4-28.6
   
Basic EPS   [+]($1.43)($1.22)($1.54)($1.29)
Diluted EPS   [+]($1.43)($1.22)($1.54)($1.29)
   
Shares outstanding (basic)   [+]109.787.843.222.2
Shares outstanding (diluted)   [+]109.787.843.222.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy